Skip to menu Skip to content Skip to footer

2015

Journal Article

Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae

Harris, Patrick N. A., Yin, Mo, Jureen, Roland, Chew, Jonathan, Ali, Jaminah, Paynter, Stuart, Paterson, David L. and Tambyah, Paul A. (2015). Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae. Antimicrobial Resistance and Infection Control, 4 (1) 14, 14.1-14.10. doi: 10.1186/s13756-015-0055-6

Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae

2015

Journal Article

Facing the challenge of multidrug-resistant gram-negative bacilli in Australia

Harris, Patrick, Paterson, David and Rogers, Benjamin (2015). Facing the challenge of multidrug-resistant gram-negative bacilli in Australia. Medical Journal of Australia, 202 (5), 243-246. doi: 10.5694/mja14.01257

Facing the challenge of multidrug-resistant gram-negative bacilli in Australia

2015

Journal Article

Antiseptic body washes for reducing the transmission of methicillin-resistant Staphylococcus aureus: A cluster crossover study

Harris, Patrick N. A., Le, Bich Diep, Tambyah, Paul, Hsu, Li Yang, Pada, Surinder, Archuleta, Sophia, Salmon, Sharon, Mukhopadhyay, Amartya, Dillon, Jasmine, Ware, Robert and Fisher, Dale A. (2015). Antiseptic body washes for reducing the transmission of methicillin-resistant Staphylococcus aureus: A cluster crossover study. Open Forum Infectious Diseases, 2 (2) ofv051, ofv051. doi: 10.1093/ofid/ofv051

Antiseptic body washes for reducing the transmission of methicillin-resistant Staphylococcus aureus: A cluster crossover study

2015

Journal Article

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial

Harris, Patrick N. A., Peleg, Anton Y., Iredell, Jon, Ingram, Paul R., Miyakis, Spiros, Stewardson, Andrew J., Rogers, Benjamin A., McBryde, Emma S., Roberts, Jason A., Lipman, Jeff, Athan, Eugene, Paul, Sanjoy K., Baker, Peter, Harris-Brown, Tiffany and Paterson, David L. (2015). Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. Trials, 16 (1) 24, 24.1-24.8. doi: 10.1186/s13063-014-0541-9

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial

2015

Journal Article

Clinical management of infections caused by enterobacteriaceae that express extended-spectrum β-Lactamase and AmpC enzymes

Harris, Patrick N. A. (2015). Clinical management of infections caused by enterobacteriaceae that express extended-spectrum β-Lactamase and AmpC enzymes. Seminars in Respiratory and Critical Care Medicine, 36 (1), 56-73. doi: 10.1055/s-0034-1398387

Clinical management of infections caused by enterobacteriaceae that express extended-spectrum β-Lactamase and AmpC enzymes

2015

Journal Article

β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: Time for a reappraisal in the era of few antibiotic options?

Harris, Patrick N. A., Tambyah, Paul A. and Paterson, David L. (2015). β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: Time for a reappraisal in the era of few antibiotic options?. The Lancet Infectious Diseases, 15 (4), 475-485. doi: 10.1016/S1473-3099(14)70950-8

β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: Time for a reappraisal in the era of few antibiotic options?

2014

Journal Article

Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults

Harris, Patrick N. A., Wang, Alvin D., Yin, Mo, Lee, Chun Kiat and Archuleta, Sophia (2014). Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults. Lancet Infectious Diseases, 14 (11), 1043-1043. doi: 10.1016/S1473-3099(14)70976-4

Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults

2014

Journal Article

What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore

Ingram, P. R., Murray, Ronan J., Cheng, Allen C., Blyth, C. C., Walls, Tony, Fisher, D. A., Davis, Josh S., Abbott, Iain, Kanapathipillai, Rupa, Madigan, Victoria, McLellan, Duncan, Briggs, Simon, King, Claire, Hurley, James, Lim, Lyn-Li, Kennedy, Karina, Wilson, Heather, Evans, Thomas, Maze, Michael, Pithie, Alan, Chong, Lauren, Leung, Grace, McCann, Sarah, Lee, Lai-yang, Wolfgang, Jill, Day, Thomas, Silva, Gustinna De, Martinello, Marianne, Gliddon, Thomas ... on behalf of the Australasian Society for Infectious Diseases Clinical Research Network (2014). What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore. Clinical Microbiology and Infection, 20 (10), O737-O744. doi: 10.1111/1469-0691.12581

What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore

2014

Journal Article

Melioidosis: refining management of a tropical time bomb

Fisher, Dale A. and Harris, Patrick N. A. (2014). Melioidosis: refining management of a tropical time bomb. The Lancet, 383 (9919), 762-764. doi: 10.1016/S0140-6736(13)62143-1

Melioidosis: refining management of a tropical time bomb

2013

Journal Article

Acute Q fever in northern Queensland: variation in incidence related to rainfall and geographical location

Harris, P., Eales, K. M., Squires, R., Govan, B. and Norton, R. (2013). Acute Q fever in northern Queensland: variation in incidence related to rainfall and geographical location. Epidemiology and Infection, 141 (5), 1034-1038. doi: 10.1017/S0950268812001495

Acute Q fever in northern Queensland: variation in incidence related to rainfall and geographical location

2012

Journal Article

Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?

Harris, P. N. A. and Ferguson, J. K. (2012). Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?. International Journal of Antimicrobial Agents, 40 (4), 297-305. doi: 10.1016/j.ijantimicag.2012.06.004

Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?

2012

Journal Article

Adhesive tape in the health care setting: another high-risk fomite?

Harris, Patrick N. A., Ashhurst-Smith, Chris, Berenger, Sandy J. and Ferguson, John K. (2012). Adhesive tape in the health care setting: another high-risk fomite?. Medical Journal of Australia, 196 (1), 34-34. doi: 10.5694/mja11.11211

Adhesive tape in the health care setting: another high-risk fomite?

2012

Journal Article

Comparison of Vitek MS (MALDI-TOF) to standard routine identification methods: an advance but no panacea

Harris, Patrick, Winney, Ian, Ashhurst-Smith, Chris, O'Brien, Mark and Graves, Stephen (2012). Comparison of Vitek MS (MALDI-TOF) to standard routine identification methods: an advance but no panacea. Pathology, 44 (6), 583-585. doi: 10.1097/PAT.0b013e328358343c

Comparison of Vitek MS (MALDI-TOF) to standard routine identification methods: an advance but no panacea

2011

Journal Article

Coxiella burnetii causing haemophagocytic syndrome: a rare complication of an unusual pathogen

Harris, P., Dixit, R. and Norton, R. (2011). Coxiella burnetii causing haemophagocytic syndrome: a rare complication of an unusual pathogen. Infection, 39 (6), 579-582. doi: 10.1007/s15010-011-0142-4

Coxiella burnetii causing haemophagocytic syndrome: a rare complication of an unusual pathogen

2011

Journal Article

Reply

Norton, R., Harris, P. and Senthuran, S. (2011). Reply. Internal Medicine Journal, 41 (9), 710-710. doi: 10.1111/j.1445-5994.2011.02558.x

Reply

2011

Journal Article

Evidence of Burkholderia pseudomallei-specific immunity in patient sera persistently nonreactive by the indirect hemagglutination assay

Harris, Patrick N. A., Williams, Natasha L., Morris, Jodie L., Ketheesan, Natkunam and Norton, Robert E. (2011). Evidence of Burkholderia pseudomallei-specific immunity in patient sera persistently nonreactive by the indirect hemagglutination assay. Clinical and Vaccine Immunology, 18 (8), 1288-1291. doi: 10.1128/CVI.00077-11

Evidence of Burkholderia pseudomallei-specific immunity in patient sera persistently nonreactive by the indirect hemagglutination assay

2011

Journal Article

Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period

Harris, P., Siew, D-A., Proud, M., Buettner, P. and Norton, R. (2011). Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period. Clinical Microbiology and Infection, 17 (8), 1216-1222. doi: 10.1111/j.1469-0691.2010.03427.x

Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period

2011

Journal Article

Challenges in the microbiological diagnosis and management of hVISA infections

Cheong, Jenny Wan Sai, Harris, Patrick, Oman, Kimberly and Norton, Robert (2011). Challenges in the microbiological diagnosis and management of hVISA infections. Pathology, 43 (4), 357-361. doi: 10.1097/PAT.0b013e3283464ca3

Challenges in the microbiological diagnosis and management of hVISA infections

2011

Journal Article

Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin

Harris, Patrick, Engler, Cathy and Norton, Robert (2011). Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin. International Journal of Antimicrobial Agents, 37 (6), 547-549. doi: 10.1016/j.ijantimicag.2011.02.001

Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin

2011

Journal Article

Automated erythrocytapheresis for severe falciparum malaria

Harris, P., Price, S., Senthuran, S., Cochupanachimootil, J. and Norton, R. (2011). Automated erythrocytapheresis for severe falciparum malaria. Internal Medicine Journal, 41 (1A), 60-63. doi: 10.1111/j.1445-5994.2010.02362.x

Automated erythrocytapheresis for severe falciparum malaria